Chihara, D., Chauhan, A., Lin, R., Mason, A., Johnson, L., Murphy, K., Henderson, J., Malpica, L., Nze, C. C., Hamilton, M., Lionel, A. C., Jain, P., Strati, P., Nair, R., Neelapu, S. S., Flowers, C., Westin, J. (2026). Phase 2 trial of epcoritamab in combination with rituximab-mini CVP for older unfit/frail or anthracycline-ineligible adult patients with newly diagnosed diffuse large B-cell lymphoma: Interim futility analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7002